Antihistamine (H1) — Anxiolytic / Sedative
Pregnancy: Avoid — particularly in first trimester and peripartum (neonatal withdrawal, QT effects). Use with extreme caution only if clearly necessary near term.
Hydroxyzine
Brand names: Atarax, Ucerax
Adult dose
Dose: Anxiety (short-term): 25mg TDS–QDS; maximum 100mg QDS (300mg daily). Pruritus: 25mg at bedtime; may increase to 25mg TDS–QDS. Pre-operative sedation: 50–100mg oral 30–60 minutes before procedure.
Route: Oral
Frequency: Three to four times daily (anxiety); once nightly (pruritus)
Max: 300mg daily (anxiety); 100mg at night (pruritus)
H1 receptor antagonist with additional anxiolytic properties — likely via anticholinergic and antihistaminergic CNS sedation. NICE recommends hydroxyzine as an option for short-term GAD treatment when SSRIs not tolerated. Non-addictive — no dependence potential. Maximum single dose in elderly: 50mg. Onset within 30 minutes (faster than buspirone). QTc prolongation — MHRA restriction on maximum dose.
Paediatric dose
Dose: 0.5 mg/kg
Route: Oral
Frequency: Three to four times daily
Max: 2mg/kg/day or 100mg/day (whichever lower)
BNFc: Pruritus: 6 months–5 years: 5–15mg daily in divided doses; 6–17 years: 15–25mg at night up to 50–100mg in divided doses. Anxiety in children: seek specialist child and adolescent psychiatry opinion. Avoid under 6 months.
Dose adjustments
Renal
Reduce dose in renal impairment — active metabolite (cetirizine) accumulates; increase dosing interval.
Hepatic
Reduce dose in hepatic impairment and extend dosing interval.
Paediatric weight-based calculator
BNFc: Pruritus: 6 months–5 years: 5–15mg daily in divided doses; 6–17 years: 15–25mg at night up to 50–100mg in divided doses. Anxiety in children: seek specialist child and adolescent psychiatry opinion. Avoid under 6 months.
Clinical pearls
- MHRA 2015: maximum dose restricted to 100mg QDS (adults) due to QTc prolongation risk — ECG recommended at baseline if cardiac risk factors
- Advantage over benzodiazepines: no dependence, no withdrawal, no abuse potential — suitable for patients with a history of substance dependence who need anxiolytic treatment
- Metabolised to cetirizine (antihistamine) — may explain some of its ongoing antipruritic effects; cetirizine can be used if hydroxyzine sedation is problematic in pruritus
- Short-term use preferred — not ideal for long-term anxiety management (sedation becomes problematic and tolerance to anxiolytic effect may develop)
Contraindications
- QT prolongation or risk factors for long QT
- Congenital long QT syndrome
- Porphyria
- Hypersensitivity to hydroxyzine, cetirizine, or aminophylline
Side effects
- Sedation (therapeutic)
- Dry mouth (anticholinergic)
- Dizziness
- Headache
- QTc prolongation (dose-dependent — MHRA 2015 restriction)
- Urinary retention (anticholinergic — caution in BPH)
- Paradoxical agitation (elderly)
Interactions
- CNS depressants, opioids, alcohol — additive sedation
- QT-prolonging drugs — additive QTc prolongation (avoid combination)
- Anticholinergic drugs — additive effects (urinary retention, dry mouth, confusion)
Monitoring
- QTc (ECG — baseline if risk factors)
- Anticholinergic side effects (urinary symptoms, constipation)
- Sedation severity
- Anxiety symptom response
Reference: BNFc; BNF 90; NICE NG106 (GAD); MHRA Hydroxyzine Safety Update 2015. Verify against your local formulary and the latest BNF before prescribing.
Related
Curated clinical cross-links plus same-class fallbacks.
Calculators
Pathways
- Acute Behavioural Disturbance / Rapid Tranquillisation · RCEM 2022; RCPsych 2022; NICE NG10
- Self-Harm Presentation · NICE NG225 (2022)
- Capacity Assessment (Mental Capacity Act) · MCA 2005; Code of Practice
- Acute Psychosis Management · NICE CG178 2014
- Depression Management · NICE CG90 2022
- Lithium Therapy Monitoring · NICE CG185 / BNF